Large Firms Lead AI Adoption Census Data Highlights Enterprise Use Arabica Coffee Futures Surge to Record High Amid USColombia Trade Tensions SEC Delays Plan Allowing for Crypto Versions of US Stocks Standard Chartered Plans to Cut Over 15 of Corporate Functions Roles Targets Higher Income per Employee Government Plans Up to 2 LIC Stake Sale Potentially Raising Rs 10000 Crore New York Fed Study Reveals Surging Gas Prices Disproportionately Burden LowerIncome Consumers TCBX Q1 2026 Earnings EPS Beats Estimates by 363 as Net Interest Income Drives Performance JBGS Q1 2026 Earnings Positive EPS Amidst Modest Market Reaction Enova International Inc Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Operational Execution MP Materials Q1 2026 Earnings Strong Profit Beat Defies Expectations DRCT Q1 2026 Earnings Narrowing Losses as EPS Surprises to the Upside CDLX Q1 2026 Earnings Adjusted Loss Narrows EPS Surprise of 4945 Beats Expectations SiNtx Technologies SINT Climbs 391 as Stock Tests Key Resistance Level GlucoTrack Inc GCTK Rebounds Sharply Bullish Momentum Building Above Support California BanCorp BCAL Gains Ground Nears Key Resistance Level Americas Gold and Silver Corporation USAS Gains 158 as Price Approaches Key Resistance Precision Drilling Corporation PDS Edges Higher as Sector Sentiment Holds Steady Iran Standoff Intensifies as Trump Rejects Counteroffer Strait of Hormuz Disruption Threatens Global Energy Markets FCF Q1 2026 Earnings EPS Misses Estimates by 857 amid Challenging Operating Environment Ucommune International Ltd UK Surges 411 Key Resistance Levels in Focus K2 Capital Acquisition Corporation Rights KTWOR Hold Steady at 022 Amid Low Volume LGL Group Shares Slip Slightly Amid LowVolume Trading NXP Semiconductors Edges Higher Amid Steady Demand in Semiconductor Sector Nuveen California Municipal Value Fund NCA Edges Higher as Bond Market Stabilizes BXP Inc BXP Holds Steady Near Support as Trading Activity Remains Subdued Spectral AI Inc Warrants MDAIW Hold Steady Near Support After Flat Session Nurix Therapeutics NRIX Rallies 230 as Buyers Test Resistance Near 1867